Showing 9 of 9 recruiting trials for “synaptic-congenital-myasthenic-syndrome”
RecruitingNCT06630650 ↗
A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes
👨⚕️ Christopher Grunseich, M.D., National Institute of Neurological Disorders and Stroke (NINDS)📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06887387 ↗
Wearable Devices for Patient Monitoring in Long QT Syndrome
👨⚕️ William J Young, MBBS, PhD, Queen Mary University of London and St Bartholomew's Hospital📍 1 site📅 Started Apr 2025View details ↗
Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution
🏥 The Foundation for Orthopaedics and Regenerative Medicine📍 3 sites📅 Started Jan 2025View details ↗
Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndrome
👨⚕️ Elina Hakonen, MD, PhD, New Children's Hospital, Helsinki University Hospital📍 1 site📅 Started Dec 2024View details ↗
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
RecruitingNCT06078553 ↗
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
Continuous Versus Intermittent cARdiac Electrical moNitorinG
👨⚕️ Joshua D Mitchell, M.D., FACC, Washington University School of Medicine📍 1 site📅 Started Nov 2023View details ↗
Comparing Direct vs Indirect Methods for Cascade Screening
RecruitingNCT06087367 ↗
Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →